KRTL Holding to merge with Industria Químico Farmacéutica Sigma S.R.L.

* KRTL Holding Group (OTCPK:KRTL [https://seekingalpha.com/symbol/KRTL]) said on Tuesday that its wholly owned subsidiary, KRTL Biotech, has completed a merger by exchange of quotas and shares agreement [https://seekingalpha.com/pr/20226109-krtl-holding-group-inc-announces-merger-with-industria-quimico-farmaceutica-sigma-corp-s-r-l]with Industria Químico Farmacéutica Sigma, a leading Bolivian pharmaceutical manufacturer.
* Under the terms of the share and quotas exchange agreement executed on September 2, 2025, the Wilstermann Family, owners of 100% of SIGMA, shall transfer 99% of SIGMA’s capital quotas to KRTL Biotech.
* In exchange, KRTL Holding, through KRTL Biotech, will issue 490M common shares of KRTL Biotech, representing 49% of KRTL Biotech’s issued and outstanding shares, to the Wilstermann Family.
* Additionally, KRTL Holding will issue one preferred share to Patricia Wilstermann, granting her a permanent board seat on KRTL Holding’s board.
* This strategic transaction preserves SIGMA’s local operations, licenses, and management while granting KRTL Biotech a majority beneficial interest in SIGMA for financial consolidation.
* SIGMA’s results will now be consolidated into KRTL Biotech’s financial statements, which are, in turn, consolidated into KRTL Holding’s reporting.

MORE ON KRTL HOLDING GROUP, INC.

* Financial information for KRTL Holding Group, Inc. [https://seekingalpha.com/symbol/KRTL/income-statement]